Reference Value. Equity as reported in the selected filing.
InsuNova Diagnostics AB (publ) - Company Valuation
Reported Book Equity
50,507 kr
Reference Value
- Based on FY
- 2025
- Valuation Date
- Business StrengthSummarises business strength from financial and public-record signals. Learn More ↗ Opens in a New Tab
- D+
- Risks
- Loss-Making
Scope & Evidence
- Company
- InsuNova Diagnostics AB (publ)
- Registration
- SE · 5593334708
- Covers
- Not stated in the filing
- Filings Used
- 4 · FY 2025, 2024, 2023, 2022
Key Ratios
- Current RatioCurrent assets divided by current liabilities. Learn More ↗ Opens in a New Tab
- -
- Quick RatioCurrent assets minus inventory, divided by current liabilities. Learn More ↗ Opens in a New Tab
- -
- Debt / EquityTotal liabilities divided by equity. Learn More ↗ Opens in a New Tab
- 0.00×
- Equity RatioEquity as a share of total assets. Learn More ↗ Opens in a New Tab
- 100.0%
- Interest CoverageEBIT divided by interest expense. Learn More ↗ Opens in a New Tab
- -
- Gross MarginGross profit as a share of revenue. Learn More ↗ Opens in a New Tab
- -
- Net Profit MarginNet profit as a share of revenue. Learn More ↗ Opens in a New Tab
- -
- Return on EquityNet profit as a share of owners' equity. Learn More ↗ Opens in a New Tab
- -67.1%
- Return on AssetsNet profit as a share of total assets. Learn More ↗ Opens in a New Tab
- -67.1%
- Revenue CAGRAverage annual revenue growth over the available period. Learn More ↗ Opens in a New Tab
- -
Earnings before interest, taxes, depreciation, and amortisation. Learn More ↗ Opens in a New Tab
Revenue, Profit & EBITDA
0 kr
-8.5k kr
-17k kr
-25.5k kr
-34k kr
2022202320242025
Net Profit